- U.S. COVID Death Toll Tops 600,000
- Health Highlights: June 16, 2021
- Even Good Weather Didn’t Lift Lockdown Blues: Study
- Strict Rest Not Recommended After Sports-Linked Concussion, Experts Say
- Is Zinc a Friend or Foe to Kidney Stones?
- Pandemic Silver Lining: Fewer Dangerous Flare-Ups for COPD Patients
- Looking for Love? Young People’s Drinking Goes Up When Dating
- Could a Type of Statin Raise Dementia Risks?
- Are Women Absorbing Toxins From Their Makeup?
- Third Dose of COVID Vaccine Boosts Protection in Transplant Recipients
Clinical Trials Update: Nov. 3, 2010
Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Hepatitis C
This study is for people with chronic hepatitis C, genotype 1. You must have had a liver biopsy less than 24 months ago without evidence of cirrhosis to qualify.
The research site is in Tamarac, Fla.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/hepatitis.aspx.
—–
Gout
This study will evaluate the cardiovascular safety of febuxostat and allopurinol in people with gout and cardiovascular disease. Participants receive study medication and related medical care at no cost, and compensation for time and travel.
The research site is in Houston, Texas.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/gout.aspx.
—–
Psoriasis
This study will evaluate the safety and tolerability of an investigational drug for moderate-to-severe chronic plaque psoriasis.
The research site is in Winston-Salem, N.C.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/psoriasis.aspx.
—–
Copyright 2010 ClinicalConnection.com. All rights reserved.
Source: HealthDay
